Agitation during transportation is one of the most ubiquitous stress conditions to which therapeutic protein formulations and other biotherapeutic …
Read Post
Protein aggregation is a major concern for biopharmaceuticals in post-production. Subvisible particles that form due to routine handling compromise …
Read Post
Silicone oil droplets represent a particle type commonly present in protein-based biotherapeutics that are especially prevalent in products packaged …
Read Post
In order to gain the most comprehensive understanding of particles in their samples, researchers often employ several instruments as part of their …
Read Post
A central challenge with particle analysis in biotherapeutics is the wide size range of particles that may be present, including particles from the …
Read Post
Subvisible particles in biotherapeutics represent critical quality attributes because they pose regulatory and potential product safety risks. …
Read Post
Particulates are ubiquitous in parenteral drug products and remain a concern throughout their development and production. These particles must be …
Read Post
In their recent publication, Quantitative Evaluation of Insoluble Particulate Matters in Therapeutic Protein Injections Using Light Obscuration and …
Read Post
In a recent paper discussing particle counting and analytical techniques, the number and type of particles present in intravitreal injection …
Read Post
The team at the University of Colorado, Boulder have long been FlowCam customers, most recently incorporating FlowCam images with artificial …
Read Post
Yokogawa Fluid Imaging Technologies' distributor to India's Biopharmaceutical market is Bioscreen Instruments. Bioscreen's Field Application …
Read Post
West Pharmaceutical Laboratories (Exton, PA) recently published a paper on a streamlined bioanalytical approach to determine the most appropriate …
Read Post